Protein Kinase Cδ Differentially Regulates Platelet Functional Responses
- 1 May 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 29 (5) , 699-705
- https://doi.org/10.1161/atvbaha.109.184010
Abstract
Objective— Protein Kinase C delta (PKCδ) is expressed in platelets and activated downstream of protease-activated receptors (PAR)s and glycoprotein VI (GPVI) receptors. The purpose of this study was to investigate the role of PKCδ in platelets. Methods and Results— We evaluated the role of PKCδ in platelets using two approaches—pharmacological and molecular genetic approach. In human platelets pretreated with isoform selective antagonistic RACK peptide (δ V1-1)TAT, and in the murine platelets lacking PKCδ, PAR4-mediated dense granule secretion was inhibited, whereas GPVI-mediated dense granule secretion was potentiated. These effects were statistically significant in the absence and presence of thromboxane A 2 (TXA 2 ). Furthermore, TXA 2 generation was differentially regulated by PKCδ. However, PKCδ had a small effect on platelet P-selectin expression. Calcium- and PKC-dependent pathways independently activate fibrinogen receptor in platelets. When calcium pathways are blocked by dimethyl-BAPTA, AYPGKF-induced aggregation in PKCδ null mouse platelets and in human platelets pretreated with (δ V1-1)TAT, was inhibited. In a FeCl 3 -induced injury in vivo thrombosis model, PKCδ −/− mice occluded similar to their wild-type littermates. Conclusions— Hence, we conclude that PKCδ differentially regulates platelet functional responses such as dense granule secretion and TXA 2 generation downstream of PARs and GPVI receptors, but PKCδ deficiency does not affect the thrombus formation in vivo.Keywords
This publication has 42 references indexed in Scilit:
- Differential regulation of threonine and tyrosine phosphorylations on protein kinase Cδ by G-protein-mediated pathways in plateletsBiochemical Journal, 2008
- Evaluation of [3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2, 3-dihydro-1H-indole-5-sulfonamide] (OXSI-2), as a Syk-selective inhibitor in plateletsEuropean Journal of Pharmacology, 2008
- Hematopoietic lineage cell–specific protein 1 (HS1) is a functionally important signaling molecule in platelet activationBlood, 2007
- Insight into intra- and inter-molecular interactions of PKC: Design of specific modulators of kinase functionPharmacological Research, 2007
- Rab27b regulates number and secretion of platelet dense granulesProceedings of the National Academy of Sciences, 2007
- Deficiency of Src homology 2 domain–containing inositol 5-phosphatase 1 affects platelet responses and thrombus growthJournal of Clinical Investigation, 2007
- Protein kinase Cδ controls self-antigen-induced B-cell toleranceNature, 2002
- Exacerbated vein graft arteriosclerosis in protein kinase Cδ–null miceJournal of Clinical Investigation, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Rottlerin, a Novel Protein Kinase InhibitorBiochemical and Biophysical Research Communications, 1994